High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...

A candy-colored story collection, sisters who lust after Hitler and harrowing reportage from a riot in India. Credit...Photo illustration by Sebastian Mast Supported by By Sam Thielman Sam Thielman is ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The consumer packaging company ...

MRI outperformed micro-ultrasound in sensitivity and negative predictive value for prostate cancer detection. Micro-ultrasound offers a short learning curve and real-time lesion identification, ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between scans or start aggressive treatment. Those with certain types of medium-risk ...

MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...